<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01238250</url>
  </required_header>
  <id_info>
    <org_study_id>2011-0320</org_study_id>
    <secondary_id>Simons Searchlight</secondary_id>
    <secondary_id>Simons VIP</secondary_id>
    <secondary_id>Simons VIP Connect</secondary_id>
    <nct_id>NCT01238250</nct_id>
  </id_info>
  <brief_title>Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight</brief_title>
  <official_title>Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Simons Searchlight</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Geisinger Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Simons Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Simons Searchlight</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Simons Searchlight collects medical, behavioral, learning, and developmental information from
      people who have gene changes that are linked to autism and other neurodevelopmental
      disorders. The goal of this study is to improve the clinical care and treatment for these
      people. Simons Searchlight partners with families to collect data and distribute it to
      qualified researchers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Simons Searchlight has expanded over the last several years to include additional gene
      changes and participation through remote formats, either online or by phone. This allows
      English and Spanish-speaking families from across the world to participate at times that are
      convenient to their schedule. Participants can donate blood, saliva, or both. These samples
      are then linked to medical, behavioral, learning, and developmental data in order to
      understand the effects of specific gene changes.

      Information provided by participants will be stripped of any personal identifying information
      and made available to qualified scientists around the world.

      The Simons Foundation, a New York-based private foundation, is committed to finding
      science-based solutions and working towards the development of targeted treatments to improve
      the lives of people who have genetic and developmental differences.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Anticipated">October 2050</completion_date>
  <primary_completion_date type="Anticipated">October 2050</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Family-Based</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Baseline comprehensive collection of medical, behavioral, learning, and developmental information of people who have documented gene changes that are associated with features of autism and other neurodevelopmental disorders.</measure>
    <time_frame>Baseline data is collected over the course of one month, on average.</time_frame>
    <description>Families with people who have specific documented gene changes that are associated with features of autism and other neurodevelopmental disorders will report detailed medical and family history information by phone. Online research surveys will be used to collect information about behavioral and learning characteristics, with the goal of improving clinical care and treatment for these people.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Longitudinal, or long-term, comprehensive collection of medical, behavioral, learning, and developmental information from people who have documented gene changes that are associated with features of autism and other neurodevelopmental disorders.</measure>
    <time_frame>Repeat data collection will occur on a regular basis and will be obtained over the course of one month, on average</time_frame>
    <description>To monitor and document the development of people who have gene changes that are related to autism and other neurodevelopmental disorders, online research surveys and updates to the family and medical history will be collected on an annual basis.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>16P11.2 Deletion Syndrome</condition>
  <condition>16p11.2 Duplications</condition>
  <condition>1Q21.1 Deletion</condition>
  <condition>1Q21.1 Microduplication Syndrome (Disorder)</condition>
  <condition>ACTL6B</condition>
  <condition>ADNP</condition>
  <condition>AHDC1</condition>
  <condition>ANK2</condition>
  <condition>ANKRD11</condition>
  <condition>ARID1B</condition>
  <condition>ASH1L</condition>
  <condition>ASXL1 Gene Mutation</condition>
  <condition>BCL11A</condition>
  <condition>CHAMP1</condition>
  <condition>CHD2</condition>
  <condition>CHD8</condition>
  <condition>CSNK2A1</condition>
  <condition>CTBP1</condition>
  <condition>CTNNB1 Gene Mutation</condition>
  <condition>CUL3</condition>
  <condition>DDX3X</condition>
  <condition>DNMT3A</condition>
  <condition>DSCAM</condition>
  <condition>DST (Dystonin) Related Epidermolysis Bullosa Simplex</condition>
  <condition>DYRK1A</condition>
  <condition>FOXP1</condition>
  <condition>GRIN2A</condition>
  <condition>GRIN2B</condition>
  <condition>HIVEP2-Related Intellectual Disability</condition>
  <condition>HNRNPH2</condition>
  <condition>KAT6A</condition>
  <condition>KATNAL2</condition>
  <condition>KDM5B</condition>
  <condition>KDM6B</condition>
  <condition>KMT2C Gene Mutation</condition>
  <condition>KMT2E</condition>
  <condition>KMT5B</condition>
  <condition>MBD5</condition>
  <condition>MED13L</condition>
  <condition>PACS1</condition>
  <condition>PBRM1</condition>
  <condition>POGZ</condition>
  <condition>PPP2R5D-Related Intellectual Disability</condition>
  <condition>PTCHD1</condition>
  <condition>PTEN Gene Mutation</condition>
  <condition>PURA</condition>
  <condition>REST</condition>
  <condition>SCN2A Encephalopathy</condition>
  <condition>SETBP1 Gene Mutation</condition>
  <condition>SETD5</condition>
  <condition>SMARCA4 Gene Mutation</condition>
  <condition>SMARCC1</condition>
  <condition>SMARCC2</condition>
  <condition>STXBP1 Encephalopathy With Epilepsy</condition>
  <condition>SYNGAP1-Related Intellectual Disability</condition>
  <condition>TBR1</condition>
  <condition>ARHGEF9</condition>
  <condition>HNRNPU</condition>
  <condition>KCNQ2-Related Epileptic Encephalopathy</condition>
  <condition>PPP3CA</condition>
  <condition>PPP2R1A</condition>
  <condition>SLC6A1</condition>
  <condition>2p16.3 Deletions</condition>
  <condition>3q29 Deletions</condition>
  <condition>3q29 Duplications</condition>
  <condition>5q35 Deletions</condition>
  <condition>5q35 Duplications</condition>
  <condition>7q11.23 Deletions</condition>
  <condition>7q11.23 Duplications</condition>
  <condition>8p23.1 Deletions</condition>
  <condition>8P23.1 Duplication Syndrome</condition>
  <condition>15q11.2-q13.1 Deletions</condition>
  <condition>15q11.2-q13.1 Duplications</condition>
  <condition>15Q13.3 Deletion Syndrome</condition>
  <condition>16p11.2 Triplications</condition>
  <condition>16P12.2 Microdeletion</condition>
  <condition>16P13.11 Microdeletion Syndrome (Disorder)</condition>
  <condition>17p11.2 Deletions</condition>
  <condition>17P11.2 Duplication Syndrome</condition>
  <condition>17q11.2 Deletions</condition>
  <condition>17Q11.2 Microduplication Syndrome (Disorder)</condition>
  <condition>17Q12 Microdeletion Syndrome (Disorder)</condition>
  <condition>17Q12 Duplication Syndrome</condition>
  <condition>17Q21.31 Deletion Syndrome</condition>
  <condition>17q21.3 Duplications</condition>
  <condition>22q11.2 Deletion Syndrome</condition>
  <condition>22Q11.2 Duplication</condition>
  <condition>22Q13.3 Deletion Syndrome</condition>
  <condition>ACTB</condition>
  <condition>ADSL</condition>
  <condition>AFF2</condition>
  <condition>ALDH5A1</condition>
  <condition>ANK3</condition>
  <condition>ARX</condition>
  <condition>ATRX Gene Mutation</condition>
  <condition>AUTS2 Syndrome</condition>
  <condition>BAZ2B</condition>
  <condition>BCKDK</condition>
  <condition>BRAF Gene Mutation</condition>
  <condition>BRSK2</condition>
  <condition>CACNA1C</condition>
  <condition>CAPRIN1</condition>
  <condition>CASK</condition>
  <condition>CASZ1</condition>
  <condition>CDKL5 Disorder</condition>
  <condition>CHD3</condition>
  <condition>CHD7</condition>
  <condition>CIC</condition>
  <condition>CNOT3</condition>
  <condition>CREBBP Gene Mutation</condition>
  <condition>CSDE1</condition>
  <condition>CTCF</condition>
  <condition>DEAF1</condition>
  <condition>DHCR7</condition>
  <condition>DLG4</condition>
  <condition>DMPK</condition>
  <condition>EBF3</condition>
  <condition>EHMT1</condition>
  <condition>EP300 Gene Mutation</condition>
  <condition>FMR1</condition>
  <condition>FOXG1 Syndrome</condition>
  <condition>GIGYF1</condition>
  <condition>GIGYF2</condition>
  <condition>GRIN1</condition>
  <condition>GRIN2D</condition>
  <condition>HRAS Gene Mutation</condition>
  <condition>IQSEC2-Related Syndromic Intellectual Disability</condition>
  <condition>IRF2BPL</condition>
  <condition>KANSL1</condition>
  <condition>KCNB1</condition>
  <condition>KCNQ3</condition>
  <condition>KDM3B</condition>
  <condition>NEXMIF</condition>
  <condition>KMT2A</condition>
  <condition>KRAS</condition>
  <condition>LZTR1</condition>
  <condition>MAGEL2</condition>
  <condition>MAP2K1 Gene Mutation</condition>
  <condition>MAP2K2 Gene Mutation</condition>
  <condition>MBOAT7</condition>
  <condition>MECP2-Related Severe Neonatal Encephalopathy</condition>
  <condition>MED12 Gene Mutation</condition>
  <condition>MEIS2</condition>
  <condition>MYT1L</condition>
  <condition>NAA15</condition>
  <condition>NBEA</condition>
  <condition>NCKAP1</condition>
  <condition>NF1 Mutation</condition>
  <condition>NIPBL</condition>
  <condition>NLGN2</condition>
  <condition>NLGN3</condition>
  <condition>NLGN4X</condition>
  <condition>NRAS</condition>
  <condition>NR4A2</condition>
  <condition>NRXN1</condition>
  <condition>NRXN2</condition>
  <condition>NRXN3</condition>
  <condition>NSD1 Gene Mutation</condition>
  <condition>PCDH19</condition>
  <condition>PHF21A</condition>
  <condition>PHF3</condition>
  <condition>PHIP</condition>
  <condition>POMGNT1</condition>
  <condition>PPP1CB</condition>
  <condition>PSMD12</condition>
  <condition>PTPN11 Gene Mutation</condition>
  <condition>RAF1 Gene Mutation</condition>
  <condition>RAI1</condition>
  <condition>RELN</condition>
  <condition>RERE</condition>
  <condition>RFX3</condition>
  <condition>RIMS1</condition>
  <condition>RIT1</condition>
  <condition>RORB</condition>
  <condition>SCN1A</condition>
  <condition>SCN8A Encephalopathy</condition>
  <condition>SETD2 Gene Mutation</condition>
  <condition>SHANK2</condition>
  <condition>SHANK3</condition>
  <condition>SHOC2</condition>
  <condition>SIN3A</condition>
  <condition>SLC9A6</condition>
  <condition>SON</condition>
  <condition>SOS1</condition>
  <condition>SOS2</condition>
  <condition>SOX5</condition>
  <condition>SPAST</condition>
  <condition>SRCAP</condition>
  <condition>TAOK1</condition>
  <condition>TANC2</condition>
  <condition>TBCK</condition>
  <condition>TCF20</condition>
  <condition>TCF4</condition>
  <condition>TLK2</condition>
  <condition>TRIO</condition>
  <condition>TRIP12</condition>
  <condition>TSC1 Gene Mutation</condition>
  <condition>TSC2 Gene Mutation</condition>
  <condition>TSHZ3</condition>
  <condition>UBE3A</condition>
  <condition>UPF3B</condition>
  <condition>USP9X</condition>
  <condition>VPS13B</condition>
  <condition>WAC</condition>
  <condition>WDFY3</condition>
  <condition>ZBTB20</condition>
  <condition>ZNF292</condition>
  <condition>ZNF462</condition>
  <condition>5P Deletion Syndrome</condition>
  <condition>2Q37 Deletion Syndrome</condition>
  <condition>9q34 Duplications</condition>
  <condition>5q15 Deletions</condition>
  <condition>5q24 Deletions</condition>
  <condition>NR3C2</condition>
  <condition>SYNCRIP</condition>
  <condition>15q15 Deletions</condition>
  <condition>Additional Genetic Changes Associated With Autism May be Added as Identified</condition>
  <arm_group>
    <arm_group_label>Copy Number Variants</arm_group_label>
    <description>Individuals with documented pathogenic or likely pathogenic copy number variants related to autism and other neurodevelopmental disorders.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Gene Variants</arm_group_label>
    <description>Individuals with documented pathogenic or likely pathogenic variants in a gene related to autism and other neurodevelopmental disorders.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood, and sometimes saliva, may be collected for the purposes of DNA analysis. Some
      samples will be used to establish a cell line to be used for research-related purposes.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The study continues to enroll and collect data from people who have the copy number
        variants, also called CNVs, and gene changes, specified above. Data is also collected from
        matched sibling control subjects and parents.

        This study has already collected data on approximately 7,000 participants, including
        approximately 4,000 carriers. Participants include people who have a gene change and at
        least one parent or guardian. Participants can also include multiple people who have a gene
        change and are within the same family.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Inclusion criteria will be any person of any age with a confirmed genetic diagnosis, or
        positive genetic testing results, in any of the following genes or genomic regions:

        Gene changes include deletions, or duplications, or both, in the copy number variants or
        changes in the single genes mentioned on the list above. This can include pathogenic,
        likely pathogenic, and in some cases, variants of unknown significance, also called VUS.

        Both biological parents are encouraged to participate. Participants must be able to speak
        and read English or Spanish fluently.

        Any person who have features of autism and has had genetic testing and a known genetic
        diagnosis may be eligible to participate. Contact the study team for more information.

        Exclusion Criteria:

        Exclusion criteria will include people who do not have the CNVs or genetic variants in the
        genes specified above, or people who do not speak and read English or Spanish.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cora Taylor, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Geisinger Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wendy Chung, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CUMC/New York-Presbyterian Morgan Stanley Children's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Simons Searchlight Study Coordinator</last_name>
    <phone>855-329-5638</phone>
    <email>coordinator@SimonsSearchlight.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>CUMC/New York-Presbyterian Morgan Stanley Children's Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wendy Chung, MD PhD</last_name>
      <phone>212-305-5890</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Geisinger Health System</name>
      <address>
        <city>Lewisburg</city>
        <state>Pennsylvania</state>
        <zip>17837</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cora Taylor, PhD</last_name>
      <phone>570-522-9430</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://simonssearchlight.org/</url>
    <description>Visit our website to register and for more information on this research study.</description>
  </link>
  <reference>
    <citation>Weiss LA, Shen Y, Korn JM, Arking DE, Miller DT, Fossdal R, Saemundsen E, Stefansson H, Ferreira MA, Green T, Platt OS, Ruderfer DM, Walsh CA, Altshuler D, Chakravarti A, Tanzi RE, Stefansson K, Santangelo SL, Gusella JF, Sklar P, Wu BL, Daly MJ; Autism Consortium. Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med. 2008 Feb 14;358(7):667-75. doi: 10.1056/NEJMoa075974. Epub 2008 Jan 9.</citation>
    <PMID>18184952</PMID>
  </reference>
  <reference>
    <citation>Simons Vip Consortium. Simons Variation in Individuals Project (Simons VIP): a genetics-first approach to studying autism spectrum and related neurodevelopmental disorders. Neuron. 2012 Mar 22;73(6):1063-7. doi: 10.1016/j.neuron.2012.02.014. Epub 2012 Mar 21.</citation>
    <PMID>22445335</PMID>
  </reference>
  <reference>
    <citation>Zufferey F, Sherr EH, Beckmann ND, Hanson E, Maillard AM, Hippolyte L, Macé A, Ferrari C, Kutalik Z, Andrieux J, Aylward E, Barker M, Bernier R, Bouquillon S, Conus P, Delobel B, Faucett WA, Goin-Kochel RP, Grant E, Harewood L, Hunter JV, Lebon S, Ledbetter DH, Martin CL, Männik K, Martinet D, Mukherjee P, Ramocki MB, Spence SJ, Steinman KJ, Tjernagel J, Spiro JE, Reymond A, Beckmann JS, Chung WK, Jacquemont S; Simons VIP Consortium; 16p11.2 European Consortium. A 600 kb deletion syndrome at 16p11.2 leads to energy imbalance and neuropsychiatric disorders. J Med Genet. 2012 Oct;49(10):660-8. doi: 10.1136/jmedgenet-2012-101203. Erratum in: J Med Genet. 2014 Jul;51(7):478.</citation>
    <PMID>23054248</PMID>
  </reference>
  <reference>
    <citation>Moreno-De-Luca A, Evans DW, Boomer KB, Hanson E, Bernier R, Goin-Kochel RP, Myers SM, Challman TD, Moreno-De-Luca D, Slane MM, Hare AE, Chung WK, Spiro JE, Faucett WA, Martin CL, Ledbetter DH. The role of parental cognitive, behavioral, and motor profiles in clinical variability in individuals with chromosome 16p11.2 deletions. JAMA Psychiatry. 2015 Feb;72(2):119-26. doi: 10.1001/jamapsychiatry.2014.2147.</citation>
    <PMID>25493922</PMID>
  </reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>November 9, 2010</study_first_submitted>
  <study_first_submitted_qc>November 9, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 10, 2010</study_first_posted>
  <last_update_submitted>April 6, 2020</last_update_submitted>
  <last_update_submitted_qc>April 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>16p11.2</keyword>
  <keyword>16p11.2 del</keyword>
  <keyword>16p11.2 deletion</keyword>
  <keyword>16p11.2 dup</keyword>
  <keyword>16p11.2 duplication</keyword>
  <keyword>chromosome 16</keyword>
  <keyword>chromosome 16p</keyword>
  <keyword>chromosome 16p11</keyword>
  <keyword>chromosome 16p11.2</keyword>
  <keyword>1q21.1</keyword>
  <keyword>1q21.1 del</keyword>
  <keyword>1q21.1 deletion</keyword>
  <keyword>1q21.1 dup</keyword>
  <keyword>1q21.1 duplication</keyword>
  <keyword>chromosome 1</keyword>
  <keyword>chromosome 1q</keyword>
  <keyword>chromosome 1q21</keyword>
  <keyword>chromosome 1q21.1</keyword>
  <keyword>genetic mutation</keyword>
  <keyword>genetic variant</keyword>
  <keyword>gene variant</keyword>
  <keyword>autism</keyword>
  <keyword>ADNP</keyword>
  <keyword>ANKRD11</keyword>
  <keyword>ARID1B</keyword>
  <keyword>ASXL3</keyword>
  <keyword>ACTL6B</keyword>
  <keyword>AHDC1</keyword>
  <keyword>BAF190</keyword>
  <keyword>ANK2</keyword>
  <keyword>ASH1L</keyword>
  <keyword>BCL11A</keyword>
  <keyword>CHD2</keyword>
  <keyword>CHD8</keyword>
  <keyword>CTNNB1</keyword>
  <keyword>CUL3</keyword>
  <keyword>DST</keyword>
  <keyword>DYRK1A</keyword>
  <keyword>FOXP1</keyword>
  <keyword>GRIN2B</keyword>
  <keyword>KDM6B</keyword>
  <keyword>KMT2E</keyword>
  <keyword>MBD5</keyword>
  <keyword>MED13L</keyword>
  <keyword>PTEN</keyword>
  <keyword>REST</keyword>
  <keyword>SCN2A</keyword>
  <keyword>SMARCC1</keyword>
  <keyword>SMARCC2</keyword>
  <keyword>SYNGAP1</keyword>
  <keyword>HIVEP2</keyword>
  <keyword>HNRNPH2</keyword>
  <keyword>PPP2R5D</keyword>
  <keyword>CHAMP1</keyword>
  <keyword>CSNK2A1</keyword>
  <keyword>CTBP1</keyword>
  <keyword>DDX3X</keyword>
  <keyword>DNMT3A</keyword>
  <keyword>DSCAM</keyword>
  <keyword>GRIN2A</keyword>
  <keyword>KAT6A</keyword>
  <keyword>KATNAL2</keyword>
  <keyword>KDM5B</keyword>
  <keyword>KMT2C</keyword>
  <keyword>KMT5B</keyword>
  <keyword>SUV420H1</keyword>
  <keyword>PACS1</keyword>
  <keyword>PBRM1</keyword>
  <keyword>PTCHD1</keyword>
  <keyword>PURA</keyword>
  <keyword>SETBP1</keyword>
  <keyword>SETD5</keyword>
  <keyword>SMARCA4</keyword>
  <keyword>STXBP1</keyword>
  <keyword>TBR1</keyword>
  <keyword>ARHGEF9</keyword>
  <keyword>HNRNPU</keyword>
  <keyword>KCNQ2</keyword>
  <keyword>PPP2B</keyword>
  <keyword>PPP2R1A</keyword>
  <keyword>SLC6A1</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>DiGeorge Syndrome</mesh_term>
    <mesh_term>Brain Diseases</mesh_term>
    <mesh_term>Intellectual Disability</mesh_term>
    <mesh_term>Cri-du-Chat Syndrome</mesh_term>
    <mesh_term>Epidermolysis Bullosa</mesh_term>
    <mesh_term>Epidermolysis Bullosa Simplex</mesh_term>
    <mesh_term>Disease</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Autistic Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Identifiers will be removed from data which will be stored in a secure database; qualified researchers can request access through the Simons Foundation Autism Research Initiative (www.SFARI.org)</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

